Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1993 2
1994 1
1996 2
1997 2
1998 10
1999 4
2000 7
2001 3
2002 6
2003 6
2004 4
2005 3
2006 7
2007 9
2008 2
2009 6
2010 3
2011 9
2012 23
2013 16
2014 25
2015 20
2016 16
2017 10
2018 13
2019 14
2020 10
2021 6
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22525829

224 results

Results by year

Filters applied: . Clear all
Page 1
[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
Blasco AJ, Arribas JR, Boix V, Clotet B, Domingo P, González-García J, Knobel H, López JC, Llibre JM, Lozano F, Miró JM, Podzamczer D, Santamaría JM, Tuset M, Zamora L, Lázaro P, Gatell JM; en representación de GESIDA. Blasco AJ, et al. Enferm Infecc Microbiol Clin. 2012 Jun;30(6):283-93. doi: 10.1016/j.eimc.2012.02.016. Epub 2012 Apr 22. Enferm Infecc Microbiol Clin. 2012. PMID: 22525829 Spanish.
[Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy].
Blasco AJ, Arribas JR, Clotet B, Domingo P, González-García J, López-Bernaldo JC, Llibre JM, Lozano F, Podzamczer D, Santamaría JM, Tuset M, Zamora L, Lázaro P, Gatell JM. Blasco AJ, et al. Enferm Infecc Microbiol Clin. 2011 Dec;29(10):721-30. doi: 10.1016/j.eimc.2011.08.003. Epub 2011 Oct 19. Enferm Infecc Microbiol Clin. 2011. PMID: 22014894 Spanish.
[Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013].
Blasco AJ, Llibre JM, Arribas JR, Boix V, Clotet B, Domingo P, González-García J, Knobel H, López JC, Lozano F, Miró JM, Podzamczer D, Santamaría JM, Tuset M, Zamora L, Lázaro P, Gatell JM; en representación de GESIDA. Blasco AJ, et al. Enferm Infecc Microbiol Clin. 2013 Nov;31(9):568-78. doi: 10.1016/j.eimc.2013.06.002. Epub 2013 Aug 20. Enferm Infecc Microbiol Clin. 2013. PMID: 23969276 Spanish.
Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Blasco AJ, Llibre JM, Berenguer J, González-García J, Knobel H, Lozano F, Podzamczer D, Pulido F, Rivero A, Tuset M, Lázaro P, Gatell JM; GESIDA ART Cost-efficacy Study Group. Blasco AJ, et al. Enferm Infecc Microbiol Clin. 2015 Mar;33(3):156-65. doi: 10.1016/j.eimc.2014.05.016. Epub 2014 Aug 28. Enferm Infecc Microbiol Clin. 2015. PMID: 25175171
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM. Rivero A, et al. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):88-99. doi: 10.1016/j.eimc.2016.06.013. Epub 2016 Jul 25. Enferm Infecc Microbiol Clin. 2017. PMID: 27459919 Free article.
Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Berenguer J, Rivero A, Blasco AJ, Arribas JR, Boix V, Clotet B, Domingo P, González-García J, Knobel H, Lázaro P, López JC, Llibre JM, Lozano F, Miró JM, Podzamczer D, Tuset M, Gatell JM; GeSIDA Antiretroviral Therapy Cost-efficacy Study Group. Berenguer J, et al. Enferm Infecc Microbiol Clin. 2016 Jun-Jul;34(6):361-71. doi: 10.1016/j.eimc.2015.07.012. Epub 2015 Aug 28. Enferm Infecc Microbiol Clin. 2016. PMID: 26321131
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
Pérez-Molina JA, Martínez E, Blasco AJ, Arribas JR, Domingo P, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Mariño A, Miró JM, Moreno S, Negredo E, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, von Wichmann MA, Gatell JM. Pérez-Molina JA, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2019 Mar;37(3):151-159. doi: 10.1016/j.eimc.2018.04.010. Epub 2018 Jun 6. Enferm Infecc Microbiol Clin (Engl Ed). 2019. PMID: 29884455 English, Spanish.
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM. Rivero A, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2018 May;36(5):268-276. doi: 10.1016/j.eimc.2017.04.002. Epub 2017 May 19. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 28532596 English, Spanish.
224 results